Future incidence and mortality of colorectal carcinoma in the United States: an updated overview of risk factors and preventative measures

Exploration of Medicine

Hassam Ali¹ 

[1] Department of Internal Medicine, East Carolina University/Vidant Medical Center, Greenville, NC 27834, USA;

关键词: colorectal carcinoma incidence;    colorectal carcinoma mortality;    colorectal carcinoma risk;    crc;    globocan;   

DOI  :  10.37349/emed.2021.00063

来源: DOAJ

【 摘 要 】

According to the Global Cancer Observatory (GLOBOCAN) 2020, colorectal carcinoma (CRC) was the second leading cause of cancer death globally. Current literature utilizes reported databases such as Surveillance, Epidemiology, and End Results (SEER) to better understand the epidemiology of CRC. The global cancer observatory’s “Cancer Tomorrow” data visualization tools were used to predict the future incidence and mortality of colorectal cancers until 2030 as a guided tool to look over ways to reduce incidence by controlling risk factors of CRC. The total number of CRC is expected to rise by 2030, with a percent change of 17.3%. The expected percent change in colon cancer is more than rectal cancer (19.8% vs. 11.6%). The estimated number of deaths secondary to CRC is expected to increase in 2030, an estimated percent change of 22.2%. The incidence and mortality rate was higher in men vs. women; however, the gap seems to be closing on trend analysis. Major risk factors for CRC include familial syndromes, family history, race, gender, obesity, diet, alcohol, and smoking. Risk can be reduced by exercise and dietary changes, fiber intake, vitamin D, calcium, and minerals. Individualized screening based on age, gender, and additional risk factors could be an option that needs further comparative data to propose a definitive benefit over established screening guidelines.

【 授权许可】

Unknown